Instituto de Medicina Molecular

Instituto de Medicina Molecular
Ivendrell · CC BY-SA 3.0 · source
Name	Instituto de Medicina Molecular
Native name	Instituto de Medicina Molecular João Lobo Antunes
Established	2001
Type	Research institute
Location	Lisbon, Portugal
Director	Maria Mota
Parent organization	University of Lisbon

Instituto de Medicina Molecular is a biomedical research institute affiliated with the University of Lisbon that focuses on translational research in molecular medicine. Founded by clinicians and scientists from the Faculty of Medicine, University of Lisbon, the institute engages with national entities such as the Fundação para a Ciência e a Tecnologia and international organizations including the European Research Council and the World Health Organization. The institute operates within a network that includes hospitals like the Santa Maria Hospital, universities such as the University of Porto and research centers like the Champalimaud Foundation and the Instituto Gulbenkian de Ciência.

History

The institute was created in 2001 by faculty from the Faculty of Medicine, University of Lisbon and leaders from the Santa Maria Hospital, with influence from figures associated with the Calouste Gulbenkian Foundation and policies shaped by the Ministry of Science, Technology and Higher Education (Portugal). Early governance included collaborations with the European Molecular Biology Organization and funding from the European Union frameworks such as the Horizon 2020 precursor programs and links to the European Research Council. Throughout its development, the institute hosted visiting scientists from institutions including the Max Planck Society, the Institut Pasteur, the National Institutes of Health, and the Wellcome Trust, and participated in consortia with the Karolinska Institutet, the Imperial College London, and the Massachusetts General Hospital.

Mission and Research Focus

The institute’s mission emphasizes translational molecular medicine, connecting clinical units like the Hospital de Santa Maria (Lisbon) and the Lisbon Academic Medical Center with basic research groups from the Faculty of Medicine, University of Lisbon and the Nova University Lisbon. Research priorities span oncology involving collaborations with the European Society for Medical Oncology, immunology tied to networks such as the International Society for Immunotherapy of Cancer, neurodegeneration connected to the Alzheimer's Association, and infectious disease aligned with the World Health Organization and the European Centre for Disease Prevention and Control. The institute aligns strategic goals with funders like the Fundação para a Ciência e a Tecnologia, foundations such as the Bill & Melinda Gates Foundation, and pan-European initiatives like the Human Brain Project.

Organizational Structure

Governance comprises a Board of Directors with members drawn from the University of Lisbon, hospital administrators from Santa Maria Hospital, and scientific advisory boards including experts from the European Research Council, the National Institutes of Health, and the Wellcome Trust. Internal structure is organized into departments and programs paralleling units at the Faculty of Medicine, University of Lisbon and cross-disciplinary centers modeled after the Broad Institute and the Cold Spring Harbor Laboratory. Administrative functions interact with entities such as the Fundação para a Ciência e a Tecnologia and the Direção-Geral da Saúde (Portugal), while ethical oversight consults with committees linked to the European Bioethics Committee and the Council of Europe.

Research Programs and Laboratories

Research programs cover cancer biology with links to projects in the European Cancer Organisation, immunology interfacing with the European Society of Clinical Microbiology and Infectious Diseases, neuroscience partnering with the Society for Neuroscience, and infectious disease studies tied to the World Health Organization consortia. Laboratories within the institute reflect methodologies adopted at the Max Planck Institute for Biology and the Institut Pasteur, including genomics units comparable to those at the Wellcome Sanger Institute, proteomics facilities akin to EMBL capabilities, and bioinformatics teams collaborating with groups at the European Bioinformatics Institute. Translational platforms work with pharmaceutical partners such as Novartis, Roche, and Pfizer and biotech firms inspired by the Biotechnology Innovation Organization network.

Collaborations and Partnerships

The institute maintains formal collaborations with the University of Lisbon, the Santa Maria Hospital, the Champalimaud Foundation, the Instituto Gulbenkian de Ciência, and international partners including the Karolinska Institutet, the Imperial College London, the Massachusetts General Hospital, the Institut Pasteur, and the Max Planck Society. It engages in EU-funded consortia with the European Commission under programs related to the Horizon Europe framework and partners with philanthropic funders such as the Calouste Gulbenkian Foundation and the Bill & Melinda Gates Foundation. Industry partnerships include collaborations with GlaxoSmithKline, Sanofi, and regional biotech clusters linked to the European Institute of Innovation and Technology.

Education and Training

Training programs are run in conjunction with the Faculty of Medicine, University of Lisbon, postgraduate courses from the Nova University Lisbon, doctoral programs partnered with the FCT PhD Studentship framework, and summer schools modeled after those of the Cold Spring Harbor Laboratory and the EMBO courses. The institute hosts postdoctoral fellows with fellowships from the Marie Skłodowska-Curie Actions, the European Research Council, and the Wellcome Trust, and organizes workshops featuring speakers from the Karolinska Institutet, the Harvard Medical School, and the Stanford University School of Medicine.

Funding and Governance

Funding sources include national grants from the Fundação para a Ciência e a Tecnologia, competitive awards from the European Research Council, philanthropic support from the Calouste Gulbenkian Foundation and the Champalimaud Foundation, and industry contracts with companies such as Roche and Novartis. Governance involves oversight by representatives from the University of Lisbon, clinical partners including the Santa Maria Hospital, and advisory input from panels associated with the European Research Council and the National Institutes of Health; accountability mechanisms mirror practices used by institutions like the Wellcome Trust and the Max Planck Society.

Category:Research institutes in Portugal Category:Medical research institutes